Skip to main content

Infant formula sales slump at Biostime but firm bullish over future growth

Sales at Chinese infant nutrition firm Biostime dropped by 14% in the first half of 2016 to RMB1.46bn (US$220m), with the Biostime brand – which accounts for 86% of the company’s sales – down 5.4% and the value brand Adimil down 65.7%.



from NutraIngredients RSS http://ift.tt/2bFiwZ4
via IFTTT

Popular posts from this blog

Photo

from Bodybuilding Motivation http://ift.tt/2EtKRn5 via IFTTT